BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38432623)

  • 1. FOXM1 Aptamer-Polyethylenimine Nanoplatform Coated With Hyaluronic Acid And AS1411 Aptamer For Dual-Targeted Delivery of Doxorubicin And Synergistic Treatment of Tumor Cells.
    Khademi Z; Yazdi KS; Ramezani M; Alibolandi M; Rezvani SA; Abnous K; Taghdisi SM
    J Pharm Sci; 2024 Mar; ():. PubMed ID: 38432623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
    Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
    Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
    Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers.
    Abdollahzade A; Rahimi H; Yaghoobi E; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Iran J Basic Med Sci; 2023; 26(10):1177-1187. PubMed ID: 37736517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeted delivery system using hollow silica nanoparticles with H
    Mirzaei S; Khademi Z; Zolfaghari R; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Drug Dev Ind Pharm; 2023 Oct; 49(10):648-657. PubMed ID: 37772892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells.
    Taghavi S; Nia AH; Abnous K; Ramezani M
    Int J Pharm; 2017 Jan; 516(1-2):301-312. PubMed ID: 27840158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer.
    Shahriari M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
    J Control Release; 2021 Jul; 335():369-388. PubMed ID: 34058270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery.
    Nie L; Sun S; Sun M; Zhou Q; Zhang Z; Zheng L; Wang L
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AS1411 aptamer modified carbon dots via polyethylenimine-assisted strategy for efficient targeted cancer cell imaging.
    Kong T; Zhou R; Zhang Y; Hao L; Cai X; Zhu B
    Cell Prolif; 2020 Jan; 53(1):e12713. PubMed ID: 31691382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411.
    Khademi Z; Ramezani M; Alibolandi M; Zirak MR; Salmasi Z; Abnous K; Taghdisi SM
    Carbohydr Polym; 2022 Sep; 292():119691. PubMed ID: 35725215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
    Mosafer J; Mokhtarzadeh A
    Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
    Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery system using silica nanoparticles coated with chitosan and AS1411 for combination therapy of doxorubicin and antimiR-21.
    Khatami F; Matin MM; Danesh NM; Bahrami AR; Abnous K; Taghdisi SM
    Carbohydr Polym; 2021 Aug; 266():118111. PubMed ID: 34044928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.
    Yaghoobi E; Zavvar T; Ramezani M; Alibolandi M; Rahimzadeh Oskuei S; Zahiri M; Alinezhad Nameghi M; Abnous K; Taghdisi SM
    J Drug Target; 2022 Dec; 30(10):1106-1112. PubMed ID: 35736221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
    Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
    Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
    Lohlamoh W; Soontornworajit B; Rotkrua P
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.
    Esawi E; Alshaer W; Mahmoud IS; Alqudah DA; Azab B; Awidi A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.